Abstract:Background 17 alpha-hydroxylase/17, 20-lyase deficiency (17-OHD) is caused by the mutations of the CYP17A1 gene. The classical phenotype of 17-OHD includes hypertension, hypokalemia, and abnormal sexual development, with partial 17-OHD typically less severe than the complete deficiency. Infertility is always one of the main clinical manifestations of partial 17-OHD. However, to date, the pregnancy potentials of partial 17-OHD female patients have rarely been investigated, and few live-birth cases have been reported among them. Moreover, the reproductive endocrine characteristics of partial 17-OHD female patients have not been completely clarified and the treatment skills of in vitro fertilization and embryo transfer (IVF-ET) have not been well summarized yet. Methods Two Chinese infertile female patients clinically diagnosed as partial 17-OHD were enrolled and their pedigree investigations were performed. Hormones were determined to depict the endocrine conditions of partial 17-OHD female patients. The adrenocorticotropic hormone (ACTH) stimulation test was performed to evaluate the functions of the adrenal cortex. Genotype analysis was conducted by next-generation sequencing (NGS) and Sanger sequencing was used to verify the results. IVF-ET was performed for the treatment of their infertility. Specifically, the progestin-primed ovarian stimulation (PPOS) protocol was chosen for the controlled ovarian hyperstimulation (COH) cycles, and the hormone replacement treatment (HRT) protocol was adopted for the endometrial preparation in frozen-thawed embryo transfer (FET) cycles. Results Hormone assays revealed a reduced estradiol (E2) and testosterone (T) level, and an elevated progesterone (P4) level. The classic ACTH stimulating test evidenced a suboptimal response of cortisol to ACTH. Genotype analysis demonstrated that the proband1 carried two variants: c.1459_1467del (p.Asp487_Phe489del)(het) and c.995T > C (p.lle332Thr)(het). The proband2 was found to be a homozygote with the mutation of c.1358T > A (p.Phe453Ser)(hom). The two female patients both succeeded in pregnancy and delivery of healthy babies through IVF-ET, with the usage of PPOS, HRT, and low-dose glucocorticoids. Conclusions Partial 17-OHD female patients manifested menstrual cycle disorders and infertility clinically; displayed high P4 and low E2 and T; showed sparse pubic hair in physical examinations; and revealed multiple ovarian cysts in ultrasonic visualization. Moreover, the pregnancy potentials of infertile partial 17-OHD women seemed to increase with the adoption of IVF-ET. Considering the sustained elevated P4 level, PPOS is a feasible protocol for them in COH.

Four novel mutations identification in 17 beta-hydroxysteroid dehydrogenase-3 deficiency and our clinical experience: possible benefits of early treatment

Prevalence of CYP17A1 Gene Mutations in 17Α-Hydroxylase Deficiency in the Chinese Han Population

Advances in the Diagnosis and Hormone Replacement Treatment of 46, XY Disorders of Sex Development

The Clinical and Molecular Heterogeneity of 17βHSD-3 Enzyme Deficiency

17Β-Hydroxysteroid Dehydrogenase 3 Deficiency: Three Case Reports and a Systematic Review.

Male pseudohermaphroditism due to 17β-hydroxysteroid dehydrogenase 3 deficiency

Preliminary Investigation of Gender Assignment in 46,XY Disorders of Sex Development with Severe Male Undermasculinisation

A3309 Clinical and Genetic Analysis of a Pedigree with Congenital Adrenal Hyperplasia (17Α-Hydroxylase /17,20-Lyase Deficiency) Literature

Clinical Characteristics and Genetic Analysis in Two Patients with 3Β-Hydroxysteroid Dehydrogenase Deficiency

A Novel Compound Heterozygous CYP17A1 Variant Causes 17α-Hydroxylase/17, 20-Lyase Deficiency.

Lessons from 17Β-Hsd3 Deficiency: Clinical Spectrum and Complex Molecular Basis in Chinese Patients

Genetic Study of a Pedigree with 17Β-Hydroxysteroid Dehydrogenase 3 Deficiency

Clinical features and genetic characteristics of 33 patients with simple virilizing form of 21-hydroxylase deficiency

[Diagnosis and Treatment of 17 Alpha-Hydroxylase Deficiency: a Case Report and Literature Review].

Diagnosis and treatment of 17α-hydroxylase deficiency:a case report and literature review

Clinical and Genetic Analysis for 10 Patients with 17α Hydroxylase/17,20 Lyase Deficiency

Reproductive endocrine characteristics and in vitro fertilization treatment of female patients with partial 17 alpha-hydroxylase deficiency: Two pedigree investigations and a literature review

Genetic spectrum and clinical characteristics of 3β-hydroxy-Δ5-C27-steroid oxidoreductase (HSD3B7) deficiency in China

Identification of Three Novel SRD5A2 Mutations in Chinese Patients with 5Α-Reductase 2 Deficiency.

New, Recurrent, and Prevalent Mutations: Clinical and Molecular Characterization of 26 Chinese Patients with 17Alpha-Hydroxylase/17,20-lyase Deficiency.

Clinical and molecular characterization of 5α-reductase type 2 deficiency due to mutations (p.Q6X, p.R246Q) in SRD5A2 gene.